Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma [0.03%]
揭秘并逆转免疫抑制细胞在肝癌治疗中的作用
Su Jong Yu,Tim F Greten
Su Jong Yu
Use of immune checkpoint inhibitors (ICIs) in hepatocellular carcinoma (HCC) has been partially successful. However, most HCC patients do not respond to immunotherapy. HCC has been shown to induce several immune suppressor mechanisms in pat...
Lipiodol Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma [0.03%]
肝细胞癌经导管动脉化疗栓塞术后的lipiodol肺炎并发症
Sungkeun Kim,Hee Yeon Kim,Su Lim Lee et al.
Sungkeun Kim et al.
Transcatheter arterial chemoembolization (TACE) is a useful palliative therapeutic modality for hepatocellular carcinoma (HCC). Postembolization syndromes, such as fever, abdominal pain, and elevated liver enzyme levels are commonly known c...
Case Reports
Journal of liver cancer. 2020 Mar;20(1):60-66. DOI:10.17998/jlc.20.1.60 2020
So Hyun Park,Bohyun Kim
So Hyun Park
Hepatocellular carcinoma (HCC) surveillance is recommended when the annual incidence of HCC exceeds 1.5%. In 2018, several international guidelines included alternative surveillance modalities, such as computed tomography and magnetic reson...
Gut-microbiome Taxonomic Profiling as Non-invasive Biomarkers for the Early Detection of Alcoholic Hepatocellular Carcinoma [0.03%]
肠道微生物群分类学谱型作为非侵入性生物标志物用于酒精性肝细胞癌早期检测的研究
Jun Seok,Ki Tae Suk
Jun Seok
Background/aims: Hepatocellular carcinoma (HCC) is a prevalent form of primary liver cancer and the fifth leading cause of worldwide cancer mortality. Though early diagnosis of HCC is important, so far lack of effective b...
Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry [0.03%]
2008年至2011年韩国肝细胞癌流行趋势分析：基于全国癌症登记数据的研究
Jun Sik Yoon,Han Ah Lee,Jun Yong Park et al.
Jun Sik Yoon et al.
Backgrounds/aims: Backgrounds/Aims: In Korea, hepatocellular carcinoma (HCC) is the sixth most common cancer and results in the second-highest cancer death rate among all cancers. We aimed to describe the characteristics ...
Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation [0.03%]
利那洛肽治疗肝移植后复发性肝癌索拉非尼耐药后的瑞戈非尼Sequential疗法成功案例报告
Soon Kyu Lee,Jeong Won Jang,Heechul Nam et al.
Soon Kyu Lee et al.
The efficacy and safety of sequential systemic therapy for the treatment of recurrent hepatocellular carcinoma (HCC) after liver transplantation (LT) are not well established. This study describes a successful experience where sequential th...
Case Reports
Journal of liver cancer. 2020 Mar;20(1):84-89. DOI:10.17998/jlc.20.1.84 2020
Histopathological Variants of Hepatocellular Carcinomas: an Update According to the 5th Edition of the WHO Classification of Digestive System Tumors [0.03%]
肝细胞癌的病理变异：根据WHO消化系统肿瘤分类第五版更新分类
Haeryoung Kim,Mi Jang,Young Nyun Park
Haeryoung Kim
Hepatocellular carcinoma (HCC) is heterogeneous in pathogenesis, phenotype and biological behavior. Various histopathological features of HCC had been sporadically described, and with the identification of common molecular alterations of HC...
A Survey of Liver Cancer Specialists' Views on the National Liver Cancer Screening Program in Korea [0.03%]
韩国肝癌专科医生对国家肝癌筛查项目的看法调查
Won Sohn,Young-Sun Lee,Jae Geun Lee et al.
Won Sohn et al.
Background/aims: To reduce the cancer burden, the Korean government initiated the National Cancer Control Plan including the National Liver Cancer Screening Program (NLCSP). Ultrasonography examinations and α-fetoprotein...